Lucid Diagnostics
LUCD
103 hedge funds and large institutions have $41M invested in Lucid Diagnostics in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 11 closing their positions.
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
68% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 19
17% more capital invested
Capital invested by funds: $35.1M → $41M (+$5.84M)
16% more funds holding
Funds holding: 89 → 103 (+14)
3.25% less ownership
Funds ownership: 23.37% → 20.13% (-3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$2M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$668K |
| 3 |
SS
Sunbelt Securities
Houston,
Texas
|
+$657K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$452K |
| 5 |
BlackRock
New York
|
+$414K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$416K |
| 2 |
LM
Luminus Management
Houston,
Texas
|
-$404K |
| 3 |
Jane Street
New York
|
-$395K |
| 4 |
Squarepoint
New York
|
-$290K |
| 5 |
Millennium Management
New York
|
-$181K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LFG
101
Larson Financial Group
St Louis,
Missouri
| $5 | – | – | – |
|
|
CIAM
102
Caitong International Asset Management
Hong Kong
| $3 | +$4 | +3 | New |
|
|
DB
103
Danske Bank
Copenhagen K,
Denmark
| $1 | – | – | – |
|
|
LM
104
Luminus Management
Houston,
Texas
| – | -$404K | -370,969 | Closed |
|
|
105
Jane Street
New York
| – | -$395K | -362,615 | Closed |
|
|
NCM
106
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$103K | -94,541 | Closed |
|
107
Citadel Advisors
Miami,
Florida
| – | -$61.3K | -56,210 | Closed |
|
|
QC
108
Quadrature Capital
London,
United Kingdom
| – | -$17.2K | -15,801 | Closed |
|
109
Pathstone Holdings
Englewood,
New Jersey
| – | -$16.3K | -14,958 | Closed |
|
|
TSS
110
Two Sigma Securities
New York
| – | -$12.6K | -11,601 | Closed |
|
|
JF
111
Jump Financial
Chicago,
Illinois
| – | -$11.7K | -10,700 | Closed |
|
|
FHA
112
Flagship Harbor Advisors
Boston,
Massachusetts
| – | -$3.27K | -3,000 | Closed |
|
|
AB
113
Amalgamated Bank
New York
| – | -$3K | -2,832 | Closed |
|
114
Rockefeller Capital Management
New York
| – | -$681 | -625 | Closed |
|
LUCD Hedge Fund Activity: Q1 2026 in Review
103 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2026, worth a combined $41M — up 17% from $35.1M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new LUCD positions and 11 closed out — a net gain of 15 holders — while 32 added to existing stakes and 19 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $2M. The largest seller was Renaissance Technologies, cutting an estimated $416K.
- 103 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2026, up from 89 in Q4 2025.
- Funds reported $41M of Lucid Diagnostics stock for Q1 2026, up 17% quarter-over-quarter.
- 26 funds opened new Lucid Diagnostics positions in Q1 2026 and 11 closed out, a net change of +15 holders.
- The largest Lucid Diagnostics buyer in Q1 2026 was Russell Investments Group, an estimated $2M added.
- The largest Lucid Diagnostics seller in Q1 2026 was Renaissance Technologies, an estimated $416K sold.
Based on aggregated 13F filings for Q1 2026.